In conclusion, we have demonstrated that mifepristone induces expression of adiponectin in adipose tissue from mice with HFD-induced obesity as well as in differentiated mouse 3T3-L1 adipocytes, and that these are associated with improvements in several key metabolic parameters. Here, ADIPOQ is linked to obesity disorder.